For the Inventor, By the Inventor

Enter assignee name

Constance, Germany

Nycomed Gmbh

USPTO Granted Patents = 63

CIPO Patents = 326

EPO Patents = 41

Trademarks = 10

Forward Citations = 382

Loading Chart...

Loading Chart...

169 inventors (with patents filed for the assignee):

Ulrich Kautz (13 out of 21 patents)

Beate Schmidt (11 out of 29 patents)

Rango Dietrich (9 out of 30 patents)

4. Hans-Peter Kley (9 out of 17 patents)

5. Dieter Flockerzi (9 out of 23 patents)

6. Rudolf Linder (7 out of 19 patents)

7. Degenhard Marx (6 out of 15 patents)

8. Rolf-Peter Hummel (5 out of 12 patents)

9. Geert Jan Sterk (4 out of 28 patents)

10. Bernd Müller (4 out of 7 patents)

11. Bernhard Kohl (4 out of 20 patents)

12. Atsuhiro Nagano (3 out of 5 patents)

13. Steffen Weinbrenner (3 out of 8 patents)

14. Andrea Wohlsen (3 out of 6 patents)

15. Hartmut Ney (3 out of 12 patents)

Core Competencies:

Ciclesonide

PDE4 Inhibitors

Respiratory Diseases

Pharmaceutical Composition

Pulmonary Surfactant

Diabetes Mellitus

Combination Medicament

Stable Pharmaceutical Products

Hydroxy-6-Heteroarylphenanthridines

Triazolophthalazines

Guanidinyl-Substituted Compounds

Isotopically Substituted Proton Pump Inhibitors

63 patents: Sort by Forward Citations

1. 8383611 - Ciclesonide containing aqueous pharmaceutical composition (2013-02-26),

2. 8371292 - Use of ciclesonide for the treatment of respiratory diseases (2013-02-12),

3. 8354535 - Salts of 6-heterocycle substituted hexahydrophenanthridine derivatives (2013-01-15),

4. 8329906 - Guanidinyl-substituted hydroxy-6-phenylphenanthridines (2012-12-11),

5. 8324404 - 3-thia-10-aza-phenanthrene derivatives (2012-12-04),

6. 8324391 - Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors (2012-12-04),

7. 8318944 - Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors (2012-11-27),

8. 8304436 - Pyrazolone derivatives as PDE4 inhibitors (2012-11-06),

9. 8288445 - Stable pharmaceutical products (2012-10-16),

10. 8278300 - Use for PDE5 inhibitors (2012-10-02),

11. 8268240 - Ciclesonide-containing sterile aqueous suspension (2012-09-18),

12. 8258124 - Combination medicament (2012-09-04),

13. 8242146 - Combination of a NSAID and a PDE-4 inhibitor (2012-08-14),

14. 8236750 - Composition comprising a pulmonary surfactant and a TNF-derived peptide (2012-08-07),

15. 8202880 - 3-hydroxy-6-phenylphenanthridines as PDE4 inhibitors (2012-06-19),

Nycomed GmbH is a pharmaceutical company based in Germany. They specialize in the development and production of innovative drugs and medical solutions. With a focus on research and development, Nycomed aims to improve patients' lives and contribute to advancements in healthcare. For more information, please visit their website.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

63 Patents

#3 in Constance

#906 in Germany

#11,184 in the World

Constance, Germany

Nycomed Gmbh

Forward Citations = 382

169 inventors:

Ulrich Kautz (13 out of 21 patents)

Beate Schmidt (11 out of 29 patents)

Rango Dietrich (9 out of 30 patents)

4. Hans-Peter Kley (9 out of 17 patents)

5. Dieter Flockerzi (9 out of 23 patents)

Please report any incorrect information to support@idiyas.com

Loading…